Skip to main content
. 2021 Mar 8;12:635539. doi: 10.3389/fmicb.2021.635539

TABLE 5.

Antimicrobial resistance profiles of V. parahaemolyticus isolates.

Antimicrobial agents Number (%) of S Number (%) of I Number (%) of R
Amoxicillin (AML) 0(0.0) 1(5.9) 16(94.1)
Ampicillin (AMP) 0(0.0) 1(5.9) 16(94.1)
Ceftriaxone (CRO) 12(70.6) 2(11.8) 3(17.6)
Cefotaxime (CTX) 11(64.7) 1(5.9) 5(29.4)
Cefixime (CFM) 11(64.7) 6(35.3) 0(0.0)
Cefoxitin (FOX) 14(82.4) 3(17.6) 0(0.0)
Meropenem (MEM) 15(88.2) 2(11.8) 0(0.0)
Imipenem (IPM) 17(100.0) 0(0.0) 0(0.0)
Nalidixic acid (NA) 17(100.0) 0(0.0) 0(0.0)
Ciprofloxacin (CIP) 15(88.2) 2(11.8) 0(0.0)
Gentamicin (CN) 14(82.4) 1(5.9) 2(11.8)
Streptomycin (S) 16(94.1) 0(0.0) 1(5.9)
Sulfamethoxazole-trimethoprim (SXT) 17(100.0) 0(0.0) 0(0.0)
Tetracycline (TE) 17(100.0) 0(0.0) 0(0.0)
Piperacillin-tazobactam (TZP) 17(100.0) 0(0.0) 0(0.0)